Patients with cancer denied best treatmentBMJ 1998; 317 doi: https://doi.org/10.1136/bmj.317.7168.1273 (Published 07 November 1998) Cite this as: BMJ 1998;317:1273
- Annabel Ferriman
Only one in five women with ovarian cancer is getting optimal treatment, a new survey from the charity CancerBACUP, reveals. Despite two reports this year from cancer specialists recommending that women be given a combination of paclitaxel and a platinum compound, few health authorities have agreed to fund the combination.
CancerBACUP's survey, which was conducted in July and August 1998, found that 48 of the 60 health authorities surveyed were not committed to providing that combination of drugs.
The survey was conducted before the Joint Council for Clinical Oncology announced their …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial